Kenneth Fong

Bio

Kenneth Fong, Ph.D., is the Chairman of Kenson Ventures, LLC. Kenson specializes in venture financing and strategic consulting to biotech companies. As of January 2003, Kenson has 18 investments that mostly fall into 3 major categories: a) Innovative Research Tools, b) Platform Technologies, and c) Drug Development. Prior to founding Kenson, Dr. Fong is the founder and former CEO of CLONTECH Laboratories, that was acquired by Becton Dickinson (BD) in late 1999. CLONTECH is the leader in the Molecular/Cell Biology market and in the last 4 years before its acquisition, the company had experienced an average growth rate of 36% a year. The company also had 48 consecutive quarters of double-digit growth and profits. In 1994, 1995, 1998, and 1999, CLONTECH was selected as one of the fastest-growing companies in the San Francisco Bay Area. Dr. Fong's past experience is best suited to young companies and those desire to grow more rapidly. He is also adept at crafting development strategy and realistic implementation plan to promote the long-term growth of company. Dr. Fong obtained his Ph.D. from Indiana University.